" class="no-js "lang="en-US"> ForQaly Medical - Medtech Alert
Monday, June 09, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
ForQaly Medical | Pharmtech Focus

ForQaly Medical

About ForQaly Medical

ForQaly Medical

ForQaly® Medical was founded in Sep. 2015, and located in Shanghai International Medical Zone (SIMZ). ForQaly® Medical is a leading, high-tech company focused on developing the percutaneous ventricular assistant device (pVAD).
The “Qaly” is short for “Quality adjusted life year”, and we named the company as “ForQaly®”, is to demonstrate our Vision as “to be a company that cares the quality and dignity of human life” simply and straight.
The company’s operation is following ISO 13485:2016 and GB/T 29490-2013. And ForQaly® got the Certificate on intellectual property management system in Aug. 2016 according to GB/T29490-2013.

Related Story

Fundraising

 Legend Capital Leads ForQaly Medical's Series B Financing | Pharmtech Focus

Legend Capital Leads ForQaly Medical's Series B Financing

October 8 2021

ForQaly Medical (hereinafter referred to as “ForQaly”), located in Shanghai Zhangjiang International Medical Zone, is […]